Traws Pharma Inc.

TRAW | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.49

-$0.05 (-8.50%)

At close: Sep 18, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $8.15M

Enterprise Value $4.33M

Beta 1.61

Average Volume 2.35M

Shares Outstanding (Diluted) 10.64M

Shares Change YoY 1164.13%

Institutional Ownership 34.02%

Exchange NASDAQ

ISIN US68232V8845

Price Performance

Price Change 1M -9.3%

Price Change 3M -45.0%

Price Change 6M -77.9%

Price Change YTD -63.2%

Price Change 1Y -76.2%

Price Change 3Y -97.5%

Price Change 5Y -99.5%

1M CAGR (ann.) -3.3%

1Y CAGR (ann.) -73.9%

5Y CAGR (ann.) -66.5%

All-Time CAGR -66.9%

Valuation

PE Ratio -0.56

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.37

PS Ratio N/A

Forward PS 0.60

PB Ratio -1.40

P/FCF Ratio -1.40

P/Adj. FCF Ratio -1.19

P/OCF Ratio -0.98

EV/Sales N/A

EV/EBIT -0.30

EV/EBITDA -0.30

EV/FCF -0.81

Earnings Yield -177.6%

FCF Yield -71.5%

Adj. FCF Yield -84.4%

Financial Health

Net Cash $3.13M

Total Debt $0

Cash & Short-Term Investments $3.13M

Total Assets $8.16M

Current Ratio 0.43

Quick Ratio 0.43

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -117.61

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -18.0%

Returns

Return on Assets -128.7%

Return on Equity 353.4%

Return on Invested Capital 283.3%

Return on Capital Employed 283.3%

Return on Tangible Assets -185.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -85.8%

Revenue CAGR 5Y -69.4%

Revenue CAGR 10Y -13.2%

EPS CAGR 3Y 76.0%

EPS CAGR 5Y 97.9%

EPS CAGR 10Y 48.5%

FCF CAGR 3Y 16.8%

FCF CAGR 5Y 4.6%

FCF CAGR 10Y -1.3%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 2

EPS Growth Next 3Y 20.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.21

EPS Growth Est (next Q) -38.2%

Revenue Est (next Q) $2.71M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $1

Price Target Upside 104.1%

Cash Flow

Operating Cash Flow $-5.33M

Free Cash Flow $-5.33M

Adj. Free Cash Flow $-6.3M

FCF Per Share -$0.50

OCF Per Share -$0.50

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-14.31M

EBITDA $-14.23M

Net Income $-14.55M

EPS (Diluted) -$0.87

Revenue / Employee N/A

Profit / Employee $-2.08M

Employees 7